Understanding the structures of Hepatitis C virus proteins

Antigenic structures of HCV envelope glycoproteins (Env)

['FUNDING_P01'] · SCRIPPS RESEARCH INSTITUTE, THE · NIH-11015064

This study is looking at the proteins on the surface of the Hepatitis C virus to understand how it infects cells and avoids the immune system, which could help create better vaccines for people affected by this virus.

Quick facts

Phase['FUNDING_P01']
Study typeNih_funding
SexAll
SponsorSCRIPPS RESEARCH INSTITUTE, THE (nih funded)
Locations1 site (LA JOLLA, UNITED STATES)
Trial IDNIH-11015064 on ClinicalTrials.gov

What this research studies

This research investigates the surface proteins of the Hepatitis C virus (HCV), which are crucial for the virus's ability to infect cells and evade the immune system. By using advanced techniques like X-ray crystallography and electron microscopy, the researchers aim to uncover the detailed structures of these proteins. This knowledge will help in designing effective vaccines against HCV, which affects a significant portion of the global population and can lead to severe liver diseases. The project focuses on understanding how these proteins interact with host cells and the immune response.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who are chronically infected with Hepatitis C virus or are at risk of infection.

Not a fit: Patients who do not have Hepatitis C virus infection or those with other unrelated health conditions may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of effective vaccines against Hepatitis C, potentially reducing the incidence of chronic liver disease and liver cancer.

How similar studies have performed: Previous research has shown promise in understanding viral structures and developing vaccines, indicating that this approach could lead to significant advancements in HCV treatment.

Where this research is happening

LA JOLLA, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.